InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,940.00
(
0.47%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,681.64
(
1.49%
)
Post# of 346054
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

entdoc

Send PM Follow Ignore
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

entdoc

Re: Threes post# 164535

Wednesday, 03/05/2014 3:56:14 PM

Wednesday, March 05, 2014 3:56:14 PM

Post# of 346054
you're right, threes: safety of Bavituximab in humans appears to be well-established. Actually, when I look back over the years of following Bavituximab's progress the most outstanding aspect of it is the elegance and thoroughness of the preclinical trials and the theoretical rationale upon which it is all based. Hats off to Dr Thorpe and his coworkers at the department of pharmacology at UTSW who have produced truly Nobel-quality work. Antiphospholipid monoclonal antibody therapy appears to have a bright future...mindboggling in its potential.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!